|
The Centers for Disease Control and Prevention (CDC) has released a new training aimed at helping pediatric medical providers recognize and prevent adverse childhood experiences (ACEs). The module focuses on the role that pediatric medical providers can play in understanding, recognizing, preventing, and treating ACEs as well as the consequences of these experiences. The training is broken up into five lessons, each featuring two succinct YouTube videos. Topics of discussion include: the biological impact of ACEs, the role of pediatric medical providers across the social ecological model, the role of pediatric medical providers in preventing ACEs, and their role in intervention. The training then concludes with a lesson on educating others and raising awareness. This training is free and can be accessed here.
 |
The Indiana State Department of Health (ISDH) receives the majority of the federal funding directed toward the State of Indiana for the purchase and distribution of naloxone. The Federal Office of Rural Health, which provides this funding, has identified 49 counties of focus within Indiana that are eligible to receive naloxone for first responders (law enforcement officers, fire departments, EMS, corrections, and schools). First responders within the 49 rural counties can receive naloxone from ISDH and training from Overdose Lifeline. If first responders within these counties are interesting in learning more, they can fill out the request form here. Additionally, as of May 2020, Governor Holcomb has directed funds toward providing naloxone for individuals, communities, and first responders who do not qualify for this opportunity. First responders who are outside the 49 rural countries and all others needing naloxone can complete the naloxone request form. Once completed, individuals will be contacted with additional information and requirements.
A local syringe exchange program administered by Aspire Indiana Health located in Madison County is experiencing setbacks. As the Madison County commissioners have yet to approve an extension of the project, Aspire Indiana Health has been unable to continue its program. The renewal of the syringe exchange program needed to be voted on by the commissioners by June 5 but was not included on the Board of Commissioners agenda, and on June 15 they adjourned without conducting any business. The commissioner of the Indiana State Department of Health, Dr. Kris Box, was scheduled to appear at the June 15 meeting to speak in support of the local program. Her appearance was canceled when it was learned the commissioners would not be conducting any business at the meeting. The president and CEO of Aspire, Barbara Scott, said that the program has been continuing to provide all other services, such as outreach, hepatitis C testing, and education. Indiana state law allowing the local syringe exchange program will expire on July 1, 2021. Recent legislation to eliminate the July expiration date failed during this year’s legislative session.
Beginning July 1st, 2020, the Indiana Health Coverage Programs (IHCP) will start to reimburse Emergency Medical Services (EMS) providers for administering naloxone. This means that EMS providers may bill for naloxone itself as well as the administration of the drug. EMS providers will be trained on how to document the naloxone’s National Drug code (NDC), found on the side of the drug label, along with other necessary components required for drug claim submission. EMS billing agencies will also receive training on how to properly submit a claim. Trainings are scheduled to start in July 2020 and webinars will be posted to the IHCP website. For a complete list of the billing details and stipulations, please view the complete program document here. If providers have any questions, please feel free to email dhscertifications@dhs.in.gov or OMPPProviderRelations@fssa.in.gov.
|
